Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) EBT: 2009-2024

Historic EBT for Tg Therapeutics (TGTX) over the last 16 years, with Dec 2024 value amounting to $25.6 million.

  • Tg Therapeutics' EBT rose 507.05% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.8 million, marking a year-over-year increase of 731.98%. This contributed to the annual value of $25.6 million for FY2024, which is 95.94% up from last year.
  • As of FY2024, Tg Therapeutics' EBT stood at $25.6 million, which was up 95.94% from $13.1 million recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' EBT registered a high of $25.6 million during FY2024, and its lowest value of -$348.1 million during FY2021.
  • Moreover, its 3-year median value for EBT was $13.1 million (2023), whereas its average is -$61.7 million.
  • Per our database at Business Quant, Tg Therapeutics' EBT plummeted by 60.56% in 2020 and then skyrocketed by 105.84% in 2023.
  • Tg Therapeutics' EBT (Yearly) stood at -$279.9 million in 2020, then decreased by 24.36% to -$348.1 million in 2021, then soared by 35.70% to -$223.8 million in 2022, then surged by 105.84% to $13.1 million in 2023, then skyrocketed by 95.94% to $25.6 million in 2024.